AI Takeaway
MetLife (MET) delivered strong Q1 FY2026 results with revenue of $19.1B (+2.7% YoY), net income surging 25.4% to $1.19B, and diluted EPS jumping 35.9% to $1.74, reflecting improved operating leverage despite a significant decline in operating cash flow.
Revenue
$19.07B
++2.72% YoY
EPS (Basic)
$1.75
++35.66% YoY
Operating Income
$1.63B
++15.27% YoY
Filed · Analysis updated · Source: SEC EDGAR 10-Q filing
MetLife grew total revenue to $19.1B in Q1 FY2026, up $505M or 2.7% year-over-year from $18.6B, suggesting steady demand across its insurance and financial services segments.
Source: Source: 10-Q Income Statement, Q1 FY2026
Operating income rose 15.3% to $1.63B, pushing the operating margin from 7.62% to 8.55%, while net margin reached 6.21%, reflecting improved cost discipline and favorable business mix.
Source: Source: 10-Q Income Statement & Key Ratios, Q1 FY2026
Diluted EPS grew 35.9% to $1.74 from $1.28, outpacing the 25.4% net income growth, likely reflecting the impact of share buybacks reducing the share count over the past year.
Source: Source: 10-Q Income Statement, Q1 FY2026
2 more insights available
Upgrade to unlockMetLife carries a debt-to-equity ratio of approximately 26.2x, with total liabilities of $715.4B against stockholders' equity of only $27.3B. While this leverage profile is common for large insurers due to policyholder liabilities, it leaves the company sensitive to adverse credit or interest rate movements that could erode the equity cushion.
Source: Source: 10-Q Balance Sheet, Q1 FY2026
Unlock 4 more detailed risk analysis
Upgrade to unlockReported EPS of $2.42 versus the $2.29 analyst consensus — a +5.5% beat for Q1 FY2026.
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $19.07B | $18.57B | +2.72% |
Operating Income | $1.63B | $1.42B | +15.27% |
Net Income | $1.19B | $945M | +25.40% |
EPS (Basic) | $1.75 | $1.29 | +35.66% |
EPS (Diluted) | $1.74 | $1.28 | +35.94% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $743.21B | $688.32B | +7.98% |
Total Liabilities | $715.41B | $660.56B | +8.30% |
Stockholders' Equity | $27.32B | $27.49B | -0.61% |
Cash & Equivalents | $22.69B | $21.33B | +6.38% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $2.69B | $4.26B | -36.95% |
Investing Cash Flow | $-5.46B | $-3.32B | -64.21% |
Financing Cash Flow | $3.56B | $220M | +1517.73% |
Share Buybacks | $755M | $1.41B | -46.49% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 8.6% | 7.6% | +0.93% |
Net Margin | 6.2% | — | — |
ROE | 4.3% | — | — |
ROA | 0.2% | — | — |
Debt to Equity | $26.182 | — | — |
Other companies in Life & Health Insurance
MetLife delivered strong Q1 FY2026 results with revenue of $19.1B (+2.7% YoY), net income of $1.19B (+25.4% YoY), and diluted EPS of $1.74 (+35.9% YoY). Operating margin also improved to 8.55% from 7.62% in the prior-year period, reflecting better cost efficiency.
The standout takeaways from MetLife's Q1 FY2026 report are the strong EPS growth of 35.9% to $1.74 and net income growth of 25.4% to $1.19B, alongside a concerning 37% drop in operating cash flow to $2.69B. The balance sheet expanded to $743.2B in total assets, but the debt-to-equity ratio remains elevated at approximately 26.2x.
Yes, MetLife's revenue grew 2.7% year-over-year to $19.1B in Q1 FY2026, up from $18.6B in the same period last year. While revenue growth was modest, the company achieved much stronger growth at the operating and net income levels due to improved margins.
Based on the financial data, key risks include a sharp 37% decline in operating cash flow to $2.69B, a highly leveraged balance sheet with a debt-to-equity ratio of ~26.2x, and stagnant stockholders' equity of $27.3B despite positive net income. Share buybacks also fell 46.5% to $755M, suggesting reduced capital return capacity.
MetLife's profitability improved meaningfully in Q1 FY2026 with net income up 25.4% and operating margins expanding, but cash flow generation weakened significantly with operating cash flow down 37% to $2.69B. The company holds $22.7B in cash and equivalents, but its highly leveraged balance sheet ($715.4B in liabilities vs. $27.3B in equity) requires careful monitoring of asset-liability management.